155 related articles for article (PubMed ID: 7651739)
1. Altered specificity of IGF2 promoter imprinting during fetal development and onset of Wilms tumour.
Taniguchi T; Schofield AE; Scarlett JL; Morison IM; Sullivan MJ; Reeve AE
Oncogene; 1995 Aug; 11(4):751-6. PubMed ID: 7651739
[TBL] [Abstract][Full Text] [Related]
2. Relaxation of IGF2 imprinting in Wilms tumours associated with specific changes in IGF2 methylation.
Sullivan MJ; Taniguchi T; Jhee A; Kerr N; Reeve AE
Oncogene; 1999 Dec; 18(52):7527-34. PubMed ID: 10602511
[TBL] [Abstract][Full Text] [Related]
3. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour.
Ogawa O; Eccles MR; Szeto J; McNoe LA; Yun K; Maw MA; Smith PJ; Reeve AE
Nature; 1993 Apr; 362(6422):749-51. PubMed ID: 8097018
[TBL] [Abstract][Full Text] [Related]
4. Loss of imprinting of IGF2 sense and antisense transcripts in Wilms' tumor.
Vu TH; Chuyen NV; Li T; Hoffman AR
Cancer Res; 2003 Apr; 63(8):1900-5. PubMed ID: 12702581
[TBL] [Abstract][Full Text] [Related]
5. Promoter-specific imprinting of the human insulin-like growth factor-II gene.
Vu TH; Hoffman AR
Nature; 1994 Oct; 371(6499):714-7. PubMed ID: 7935819
[TBL] [Abstract][Full Text] [Related]
6. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour.
Steenman MJ; Rainier S; Dobry CJ; Grundy P; Horon IL; Feinberg AP
Nat Genet; 1994 Jul; 7(3):433-9. PubMed ID: 7920665
[TBL] [Abstract][Full Text] [Related]
7. Aberrant imprinting of the insulin-like growth factor II receptor gene in Wilms' tumor.
Xu YQ; Grundy P; Polychronakos C
Oncogene; 1997 Mar; 14(9):1041-6. PubMed ID: 9070652
[TBL] [Abstract][Full Text] [Related]
8. Alterations in the promoter-specific imprinting of the insulin-like growth factor-II gene in Wilms' tumor.
Vu TH; Hoffman A
J Biol Chem; 1996 Apr; 271(15):9014-23. PubMed ID: 8621549
[TBL] [Abstract][Full Text] [Related]
9. Constitutional relaxation of insulin-like growth factor II gene imprinting associated with Wilms' tumour and gigantism.
Ogawa O; Becroft DM; Morison IM; Eccles MR; Skeen JE; Mauger DC; Reeve AE
Nat Genet; 1993 Dec; 5(4):408-12. PubMed ID: 8298652
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of the insulin-like growth factor-II gene in Wilms' tumor is not dependent on loss of genomic imprinting or loss of heterozygosity.
Wang WH; Duan JX; Vu TH; Hoffman AR
J Biol Chem; 1996 Nov; 271(44):27863-70. PubMed ID: 8910385
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor II and WT1 transcript localization in human fetal kidney and Wilms' tumor.
Yun K; Fidler AE; Eccles MR; Reeve AE
Cancer Res; 1993 Nov; 53(21):5166-71. PubMed ID: 8221652
[TBL] [Abstract][Full Text] [Related]
12. Promoter-specific insulin-like growth factor 2 gene imprinting in human fetal liver and hepatoblastoma.
Yun K; Jinno Y; Sohda T; Niikawa N; Ikeda T
J Pathol; 1998 May; 185(1):91-8. PubMed ID: 9713365
[TBL] [Abstract][Full Text] [Related]
13. Hypomethylation of the P3 promoter is associated with up-regulation of IGF2 expression in human osteosarcoma.
Li Y; Meng G; Huang L; Guo QN
Hum Pathol; 2009 Oct; 40(10):1441-7. PubMed ID: 19427670
[TBL] [Abstract][Full Text] [Related]
14. Promoter-dependent tissue-specific expressive nature of imprinting gene, insulin-like growth factor II, in human tissues.
Wu HK; Squire JA; Song Q; Weksberg R
Biochem Biophys Res Commun; 1997 Apr; 233(1):221-6. PubMed ID: 9144427
[TBL] [Abstract][Full Text] [Related]
15. The human insulin-like growth factor-II promoter P1 is not restricted to liver: evidence for expression of P1 in other tissues and for a homologous promoter in baboon liver.
Jin IH; Sinha G; Yballe C; Vu TH; Hoffman AR
Horm Metab Res; 1995 Oct; 27(10):447-9. PubMed ID: 8575722
[TBL] [Abstract][Full Text] [Related]
16. Relaxation of imprinting of human insulin-like growth factor II gene, IGF2, in sporadic breast carcinomas.
Wu HK; Squire JA; Catzavelos CG; Weksberg R
Biochem Biophys Res Commun; 1997 Jun; 235(1):123-9. PubMed ID: 9196048
[TBL] [Abstract][Full Text] [Related]
17. Promoter-specific expression of the imprinted IGF2 gene in cattle (Bos taurus).
Curchoe C; Zhang S; Bin Y; Zhang X; Yang L; Feng D; O'Neill M; Tian XC
Biol Reprod; 2005 Dec; 73(6):1275-81. PubMed ID: 16120826
[TBL] [Abstract][Full Text] [Related]
18. Maintenance of genomic imprinting at the IGF2 locus in hepatoblastoma.
Davies SM
Cancer Res; 1993 Oct; 53(20):4781-3. PubMed ID: 8402661
[TBL] [Abstract][Full Text] [Related]
19. Developmental-dependent DNA methylation of the IGF2 and H19 promoters is correlated to the promoter activities in human liver development.
Li X; Gray SG; Flam F; Pietsch T; Ekström TJ
Int J Dev Biol; 1998 Jul; 42(5):687-93. PubMed ID: 9712523
[TBL] [Abstract][Full Text] [Related]
20. Chromatin structure and imprinting: developmental control of DNase-I sensitivity in the mouse insulin-like growth factor 2 gene.
Feil R; Handel MA; Allen ND; Reik W
Dev Genet; 1995; 17(3):240-52. PubMed ID: 8565330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
